Literature DB >> 15292274

Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stress.

Susanne Naegele1, Simon J Morley.   

Abstract

To investigate the role for initiation factor phosphorylation in de novo translation, we have studied the recovery of human kidney cells from hypertonic stress. Previously, we have demonstrated that hypertonic shock causes a rapid inhibition of protein synthesis, the disaggregation of polysomes, the dephosphorylation of eukaryotic translation initiation factor (eIF)4E, 4E-BP1, and ribosomal protein S6, and increased association of 4E-BP1 with eIF4E. The return of cells to isotonic medium promotes a transient activation of Erk1/2 and the phosphorylation of initiation factors, promoting an increase in protein synthesis that is independent of a requirement for eIF4E phosphorylation. As de novo translation is associated with the phosphorylation of 4E-BP1, we have investigated the role of the signaling pathways required for this event by the use of cell-permeable inhibitors. Surprisingly, although rapamycin, RAD001, wortmannin, and LY294002 inhibited the phosphorylation of 4E-BP1 and its release from eIF4E, they did not prevent the recovery of translation rates. These data suggest that only a small proportion of the available eIF4F complex is required for maximal translation rates under these conditions. Similarly, prevention of Erk1/2 activity alone with low concentrations of PD184352 did not impinge upon de novo translation until later times of recovery from salt shock. However, U0126, which prevented the phosphorylation of Erk1/2, ribosomal protein S6, TSC2, and 4E-BP1, attenuated de novo protein synthesis in recovering cells. These results indicate that the phosphorylation of 4E-BP1 is mediated by both phosphatidylinositol 3-kinase-dependent rapamycin-sensitive and Erk1/2-dependent signaling pathways and that activation of either pathway in isolation is sufficient to promote de novo translation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292274     DOI: 10.1074/jbc.M404945200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Regulation of mRNA translation by signaling pathways.

Authors:  Philippe P Roux; Ivan Topisirovic
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

2.  Interactions of everolimus and sorafenib in pancreatic cancer cells.

Authors:  Dipti K Pawaskar; Robert M Straubinger; Gerald J Fetterly; Wen W Ma; William J Jusko
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

3.  Orexin/hypocretin activates mTOR complex 1 (mTORC1) via an Erk/Akt-independent and calcium-stimulated lysosome v-ATPase pathway.

Authors:  Zhiqiang Wang; Shimeng Liu; Miyo Kakizaki; Yuuki Hirose; Yukiko Ishikawa; Hiromasa Funato; Masashi Yanagisawa; Yonghao Yu; Qinghua Liu
Journal:  J Biol Chem       Date:  2014-10-02       Impact factor: 5.157

4.  A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies.

Authors:  Maria Alexandra Andrei; Dierk Ingelfinger; Rainer Heintzmann; Tilmann Achsel; Rolando Rivera-Pomar; Reinhard Lührmann
Journal:  RNA       Date:  2005-05       Impact factor: 4.942

5.  The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity.

Authors:  David Shahbazian; Philippe P Roux; Virginie Mieulet; Michael S Cohen; Brian Raught; Jack Taunton; John W B Hershey; John Blenis; Mario Pende; Nahum Sonenberg
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

6.  Translation initiation factor 4E inhibits differentiation of erythroid progenitors.

Authors:  Montserrat Blázquez-Domingo; Godfrey Grech; Marieke von Lindern
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  The structure of eukaryotic translation initiation factor-4E from wheat reveals a novel disulfide bond.

Authors:  Arthur F Monzingo; Simrit Dhaliwal; Anirvan Dutt-Chaudhuri; Angeline Lyon; Jennifer H Sadow; David W Hoffman; Jon D Robertus; Karen S Browning
Journal:  Plant Physiol       Date:  2007-02-23       Impact factor: 8.340

8.  Role of the mTOR pathway in LPS-activated monocytes: influence of hypertonic saline.

Authors:  Valérie Schaeffer; Saman Arbabi; Iris A Garcia; Megan L Knoll; Joseph Cuschieri; Eileen M Bulger; Ronald V Maier
Journal:  J Surg Res       Date:  2010-06-09       Impact factor: 2.192

9.  Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice.

Authors:  Dipti K Pawaskar; Robert M Straubinger; Gerald J Fetterly; Bonnie H Hylander; Elizabeth A Repasky; Wen W Ma; William J Jusko
Journal:  Cancer Chemother Pharmacol       Date:  2013-03-03       Impact factor: 3.333

10.  Differentiation-induced post-transcriptional control of B7-H1 in human trophoblast cells.

Authors:  L M Holets; M Z Carletti; S K Kshirsagar; L K Christenson; M G Petroff
Journal:  Placenta       Date:  2008-11-17       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.